IMPROVE bleeding risk score: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
The IMPROVE bleeding risk score estimates the risk of bleeding among acutely ill hospitalized patients.<ref name="pmid20453069">{{cite journal| author=Decousus H, Tapson VF, Bergmann JF, Chong BH, Froehlich JB, Kakkar AK et al.| title=Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. | journal=Chest | year= 2011 | volume= 139 | issue= 1 | pages= 69-79 | pmid=20453069 | doi=10.1378/chest.09-3081 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20453069 }} </ref> | |||
==IMPROVE Bleeding Risk Score== | ==IMPROVE Bleeding Risk Score== |
Revision as of 14:27, 27 May 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]
Overview
The IMPROVE bleeding risk score estimates the risk of bleeding among acutely ill hospitalized patients.[1]
IMPROVE Bleeding Risk Score
Calculation of the IMPROVE Bleeding Risk Score
Variable | Score[1] |
Active gastric or duodenal ulcer | 4.5 |
Prior bleeding within the last 3 months | 4 |
Thrombocytopenia (<50x109/L) | 4 |
Age ≥ 85 years | 3.5 |
Liver failure (INR>1.5) | 2.5 |
Severe kidney failure (GFR< 30 mL/min/m2) | 2.5 |
Admission to ICU or CCU | 2.5 |
Central venous catheter | 2 |
Rheumatic disease | 2 |
Active malignancy | 2 |
Age: 40-84 years | 1.5 |
Male | 1 |
Moderate kidney failure (GFR: 30-59 mL/min/m2) | 1 |
Interpretation of the IMPROVE Bleeding Risk Score
The IMPROVE risk score for bleeding can be interpreted as such:[1]
- Score ≥7: Elevated risk of bleeding
- Score <7: Not elevated risk of bleeding
References
- ↑ 1.0 1.1 1.2 Decousus H, Tapson VF, Bergmann JF, Chong BH, Froehlich JB, Kakkar AK; et al. (2011). "Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators". Chest. 139 (1): 69–79. doi:10.1378/chest.09-3081. PMID 20453069.